Table of Contents

2019-2024 Global Follicle Stimulating Hormone Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Follicle Stimulating Hormone Consumption 2014-2024
  • 2.1.2 Follicle Stimulating Hormone Consumption CAGR by Region
• 2.2 Follicle Stimulating Hormone Segment by Type
  • 2.2.1 Recombinant FSH
  • 2.2.2 Urinary FSH
• 2.3 Follicle Stimulating Hormone Consumption by Type
  • 2.3.1 Global Follicle Stimulating Hormone Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Follicle Stimulating Hormone Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Follicle Stimulating Hormone Sale Price by Type (2014-2019)
• 2.4 Follicle Stimulating Hormone Segment by Application
  • 2.4.1 Infertility Treatment
  • 2.4.2 Assisted Reproductive Technology
• 2.5 Follicle Stimulating Hormone Consumption by Application
  • 2.5.1 Global Follicle Stimulating Hormone Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Follicle Stimulating Hormone Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Follicle Stimulating Hormone Sale Price by Application (2014-2019)

3 Global Follicle Stimulating Hormone by Players

• 3.1 Global Follicle Stimulating Hormone Sales Market Share by Players
  • 3.1.1 Global Follicle Stimulating Hormone Sales by Players (2017-2019)
  • 3.1.2 Global Follicle Stimulating Hormone Sales Market Share by Players (2017-2019)
• 3.2 Global Follicle Stimulating Hormone Revenue Market Share by Players
  • 3.2.1 Global Follicle Stimulating Hormone Revenue by Players (2017-2019)
  • 3.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Players (2017-2019)
• 3.3 Global Follicle Stimulating Hormone Sale Price by Players
• 3.4 Global Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Follicle Stimulating Hormone Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Follicle Stimulating Hormone Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Follicle Stimulating Hormone by Regions

• 4.1 Follicle Stimulating Hormone by Regions
  • 4.1.1 Global Follicle Stimulating Hormone Consumption by Regions
  • 4.1.2 Global Follicle Stimulating Hormone Value by Regions
• 4.2 Americas Follicle Stimulating Hormone Consumption Growth
• 4.3 APAC Follicle Stimulating Hormone Consumption Growth
• 4.4 Europe Follicle Stimulating Hormone Consumption Growth
• 4.5 Middle East & Africa Follicle Stimulating Hormone Consumption Growth

5 Americas

• 5.1 Americas Follicle Stimulating Hormone Consumption by Countries
  • 5.1.1 Americas Follicle Stimulating Hormone Consumption by Countries (2014-2019)
  • 5.1.2 Americas Follicle Stimulating Hormone Value by Countries (2014-2019)
• 5.2 Americas Follicle Stimulating Hormone Consumption by Type
• 5.3 Americas Follicle Stimulating Hormone Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Follicle Stimulating Hormone Consumption by Countries
  • 6.1.1 APAC Follicle Stimulating Hormone Consumption by Countries (2014-2019)
  • 6.1.2 APAC Follicle Stimulating Hormone Value by Countries (2014-2019)
• 6.2 APAC Follicle Stimulating Hormone Consumption by Type
• 6.3 APAC Follicle Stimulating Hormone Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Follicle Stimulating Hormone by Countries
  • 7.1.1 Europe Follicle Stimulating Hormone Consumption by Countries (2014-2019)
  • 7.1.2 Europe Follicle Stimulating Hormone Value by Countries (2014-2019)
• 7.2 Europe Follicle Stimulating Hormone Consumption by Type
• 7.3 Europe Follicle Stimulating Hormone Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Follicle Stimulating Hormone by Countries
  • 8.1.1 Middle East & Africa Follicle Stimulating Hormone Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Follicle Stimulating Hormone Value by Countries (2014-2019)
• 8.2 Middle East & Africa Follicle Stimulating Hormone Consumption by Type
• 8.3 Middle East & Africa Follicle Stimulating Hormone Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Follicle Stimulating Hormone Distributors
• 10.3 Follicle Stimulating Hormone Customer

11 Global Follicle Stimulating Hormone Market Forecast

• 11.1 Global Follicle Stimulating Hormone Consumption Forecast (2019-2024)
• 11.2 Global Follicle Stimulating Hormone Forecast by Regions
  • 11.2.1 Global Follicle Stimulating Hormone Forecast by Regions (2019-2024)
  • 11.2.2 Global Follicle Stimulating Hormone Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Follicle Stimulating Hormone Forecast by Type
• 11.8 Global Follicle Stimulating Hormone Forecast by Application

12 Key Players Analysis

• 12.1 Merck Serono
  • 12.1.1 Company Details
  • 12.1.2 Follicle Stimulating Hormone Product Offered
  • 12.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Merck Serono News
• 12.2 MSD
  • 12.2.1 Company Details
  • 12.2.2 Follicle Stimulating Hormone Product Offered
  • 12.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 MSD News
• 12.3 IBSA
  • 12.3.1 Company Details
  • 12.3.2 Follicle Stimulating Hormone Product Offered
  • 12.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 IBSA News
• 12.4 Ferring
  • 12.4.1 Company Details
  • 12.4.2 Follicle Stimulating Hormone Product Offered
  • 12.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Ferring News
• 12.5 Livzon
  • 12.5.1 Company Details
  • 12.5.2 Follicle Stimulating Hormone Product Offered
  • 12.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Livzon News
• 12.6 Techwell
  • 12.6.1 Company Details
  • 12.6.2 Follicle Stimulating Hormone Product Offered
  • 12.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Techwell News
• 12.7 GenSci
  • 12.7.1 Company Details
  • 12.7.2 Follicle Stimulating Hormone Product Offered
  • 12.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 GenSci News
• 12.8 Gedeon Richter
  • 12.8.1 Company Details
  • 12.8.2 Follicle Stimulating Hormone Product Offered
  • 12.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Gedeon Richter News
• 12.9 Teva
  • 12.9.1 Company Details
  • 12.9.2 Follicle Stimulating Hormone Product Offered
  • 12.9.3 Teva Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Teva News

13 Research Findings and Conclusion

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). It is mainly used to treat infertility disease and assisted reproductive technology. At present, this product cannot be replaced in the treatment of infertility.
Currently, There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are top two companies in the world. In 2016, Merck Serono takes about 58.70% of global follicle stimulating hormone revenue. MSD takes about 26.29% of global follicle stimulating hormone revenue.

According to this study, over the next five years the Follicle Stimulating Hormone market will register a 3.7% CAGR in terms of revenue, the global market size will reach US$ 1550 million by 2024, from US$ 1250 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Follicle Stimulating Hormone business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Follicle Stimulating Hormone market by product type, application, key manufacturers and key regions and countries.

This study considers the Follicle Stimulating Hormone value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Recombinant FSH
Urinary FSH
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Infertility Treatment
Assisted Reproductive Technology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Follicle Stimulating Hormone consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Follicle Stimulating Hormone market by identifying its various subsegments.
Focuses on the key global Follicle Stimulating Hormone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Follicle Stimulating Hormone with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Follicle Stimulating Hormone submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.